- Correction
- Open access
- Published:
Correction: Detailed statistical analysis plan for ALBINO: effect of Allopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome — a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III)
Trials volume 25, Article number: 192 (2024)
The Original Article was published on 24 January 2024
Correction: Trials 25, 81 (2024)
https://doi.org/10.1186/s13063-023-07828-6
Following publication of the original article [1], we have been notified that updates were needed to the Recruiting Hospitals and Local Principal Investigator list of the ALBINO study group in the acknowledgement section.
Names originally included, but removed with this correction:
Germany: Stefan Winkler, Universitätsklinikum C. G. Carus - Medizinische Fakultät der TU Dresden, Barbara Seipold, Universitätsklinikum C. G. Carus - Medizinische Fakultät der TU Dresden
Names originally missing, but included with this correction:
Austria: Martin Wald
Finland: Kristiina Saarinen and Krista Rantakari
Germany: Lübeck Philipp Jung, Universitätsklinik für Kinder- und Jugendmedizin, Birgit Kampschulte, Department of General Pediatrics and Neonatology, Justus‑Liebig‑University Gießen, Thomas Michael Volkl, KJF Klinik Josefinum, Anna Koluch, AUF DER BULT Kinder- und Jugendkrankenhaus Hannover, Patrick Mohrhart, Universitätsklinikum Erlangen, Jenny Potratz, Universitätsklinikum Münster Torsten Ott
Netherlands: Gerbrich Engelien van den Bosch, Erasmus MC – Sophia Children’s Hospital, Marianne van der Heide, Isala Kliniek Zwolle, Carien C.C.J.M Smeets, Sint Elisabeth Ziekenhuis Tillburg
Spain: Ana Concheiro Guisá, Complejo Hospitalario Universitario Vigo
Switzerland: Mara Hesse, UniversitaetsSpital Zuerich, Bjarte Rogdo, Kantonsspital Graubünden (Chur), Philipp Meyer, Kantonsspital Aarau AG, Vera Bernet, Spital Zöllikerberg
The original article has been corrected.
Reference
Engel C, et al. Detailed statistical analysis plan for ALBINO: effect of Allopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome — a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III). Trials. 2024;25:81. https://doi.org/10.1186/s13063-023-07828-6.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Engel, C., Rüdiger, M., Benders, M.J.N.L. et al. Correction: Detailed statistical analysis plan for ALBINO: effect of Allopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome — a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III). Trials 25, 192 (2024). https://doi.org/10.1186/s13063-024-08031-x
Published:
DOI: https://doi.org/10.1186/s13063-024-08031-x